O=C(Cn1cnc2sc3c(c2c1=O)CCCC3)NCC(=O)Nc1c(F)cc(F)cc1Br
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?